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Abstract: Both dietary fat and vitamin D deficiency have been linked with increased incidence of
non-alcoholic fatty liver disease and insulin resistance. While sex differences in disease prevalence
and severity are well known, the impact on disease pathogenesis remains unclear. To further explore
the effect of these exposures on metabolic function, C57BL/6 male and female mice were weaned
onto one of four diets; low fat vitamin D replete, low fat vitamin D deficient, or two high fat diets,
one vitamin D replete and one deficient. Visceral fat, hepatic adiposity, and insulin resistance were
measured after five and a half weeks. Vitamin D deficiency, independent of dietary fat, increased
hepatic fat accumulation in both sexes (p = 0.003), although did not increase hepatic expression of
interleukin-6 (p = 0.92) or tumor necrosis factor-α (p = 0.78). Males were observed to have greater
insulin resistance (glucose area under the curve: p < 0.001, homeostatic model assessment for insulin
resistance: p = 0.046), and have greater visceral adiposity (p < 0.001), while female mice had greater
hepatic fat accumulation (p < 0.001). This study is the first to demonstrate vitamin D deficiency alone
can cause hepatic accumulation while also being the first to observe higher liver fat percentages in
female mice.
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1. Introduction
Metabolic syndrome is a major health concern, with disease prevalence growing across the
world [1]. With this metabolic dysfunction comes an increased risk of a wide range of related diseases,
such as non-alcoholic fatty liver disease (NAFLD), insulin resistance, and type II diabetes [2,3].
Non-alcoholic fatty liver disease is a spectrum of diseases that affects around 25% of western
populations. It can arise as simple fat accumulation in the liver, or progress through to non-alcoholic
steatohepatitis, liver fibrosis, and finally liver cirrhosis [4]. Insulin resistance and type II diabetes are
characterized by impaired insulin sensitivity and later in the disease, impaired insulin secretion [5].
Interestingly, there is evidence for sex differences in the prevalence and risk profile of these
metabolic conditions. Epidemiological studies have shown that males have a higher risk of
NAFLD [6,7], insulin resistance [8], type II diabetes [9], and metabolic syndrome [10] than females,
whereas females tend to have more severe disease [9,11]. Despite these disparities between sexes, few
experimental studies have directly assessed the impact of sex on metabolic dysfunction and disease
progression [12,13].
While NAFLD, insulin resistance, and metabolic syndrome are connected in their prevalence
and comorbidity, there remain questions as to what may be the driving factors connecting them.
One possibility is vitamin D deficiency, which is widespread in developed countries [14] with
prevalence increasing concomitantly with metabolic dysfunction [15]. Several association studies have
linked vitamin D deficiency with metabolic syndrome [15], type II diabetes [16], insulin resistance [17],
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and NAFLD [18,19]. However, these associations are potentially confounded by the impact of chronic
disease on physical activity levels which may limit sun exposure and, as a consequence, vitamin D
synthesis [20].
Some experimental studies have addressed this issue. For example, a study by Roth and
colleagues [21] found that vitamin D deficiency in combination with a western diet, but not alone,
increased NAFLD and insulin resistance in male Sprague Dawley rats. Interestingly, vitamin D
deficiency alone was sufficient to decrease insulin sensitivity. Geldenhuys et al. [22] found a similar
effect in male mice whereby low serum vitamin D concentrations, in combination with a high fat diet,
increased markers of NAFLD. Although, in contrast to the previous study, there was no evidence
of vitamin D deficiency induced insulin resistance. As such, the impact of vitamin D deficiency on
metabolic dysfunction requires further clarification. As highlighted earlier, both studies focused on
male animals so the effect of sex on these responses is unclear.
This study aimed to assess the impact of vitamin D deficiency, alone or in combination with a
high fat diet, on markers of metabolic function including visceral adiposity, hepatic lipid accumulation,
and insulin sensitivity. We also compared these parameters between male and female mice to assess if
sex influences the response to vitamin D deficiency and/or a high fat diet.
2. Materials and Methods
All experiments were performed according to the ethical guidelines of the National Health and
Medical Research Council of Australia and with ethics approval from the University of Tasmania
Animal Ethics Committee (Ethics No. A0015359). C57BL/6 mice were purchased from Jackson
Laboratories (Bar Harbor, ME, USA) and housed at the Cambridge Animal Facility (University
of Tasmania, Hobart, Australia). Prior to weaning, all mice, and their mothers, were kept on a
low fat vitamin D replete diet (described below). After weaning, the mice were split into one of
four experimental diets (described below) and maintained on these diets for five and a half weeks.
Mice were separated by diet and sex and housed in a temperature controlled environment with
a 12 h light/dark cycle and ad libitum access to water and the assigned diet. At eight weeks of age,
following an overnight fast, a glucose tolerance test was performed. After three days’ recovery animals
were overnight fasted a second time before being euthanized by interperitoneal injection of sodium
pentobarbital (60 mg/kg bodyweight). At this time blood was taken for insulin and 25-hydroxy
vitamin D (25(OH)D) measurements and tissue was harvested. An overview of the experimental
protocol is shown in Figure 1.
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Figure 1. Experimental overview: Mice were weaned at three weeks of age separated by sex and 
assigned to one of the four experimental diets; low fat vitamin D replete (LF+), low fat vitamin D 
deficient (LF−), high fat vitamin D replete (HF+), or high fat vitamin D deficient (HF−). At eight weeks 
of age a glucose tolerance test (GTT) was performed, after three days’ recovery animals were 
sacrificed and tissue was harvested and stored for further analysis. 
2.1. Dietary Intervention 
At weaning, mice were assigned to one of four experimental diets, identical to those previously 
described by Geldenhuys et al. [22] (Table 1). These included a low fat (5% wt/wt fat) feed containing 
Figure 1. Experimental overview: Mice were weaned at three weeks of age separated by sex and
assigned to one of the four experimental diets; low fat vitamin D replete (LF+), low fat vitamin D
deficient (LF−), high fat vitamin D replete (HF+), or high fat vitamin D deficient (HF−). At eight weeks
of age a glucose tolerance test (GTT) was performed, after three days’ recovery animals were sacrificed
and tissue was harvested and stored for further analysis.
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2.1. Dietary Intervention
At weaning, mice were assigned to one of four experimental diets, identical to those previously
described by Geldenhuys et al. [22] (Table 1). These included a low fat (5% wt/wt fat) feed containing
either 2280 IU of vitamin D3/kg (LF+), or no added vitamin D3 (LF−), and a high fat (23.6% wt/wt fat)
feed that also either contained 2280 IU of vitamin D3/kg (HF+), or no added vitamin D3 (HF−)
(Specialty Feeds; Glen Forrest, Western Australia, Australia). The vitamin D deficient feeds were
supplemented with 2% calcium, while the vitamin D replete feeds were supplemented with 1% calcium
to ensure normocalcemia [23].
Table 1. Nutrient composition of low and high fat diets.
Diet
Carbohydrate Protein Fat Micronutrients *
Sucrose Starch Fiber Casein Canola Oil Lard
Low Fat 10.0 53.4 5.0 20.0 5.0 - 6.6
High Fat 10.0 30.6 5.0 20.0 2.9 20.7 10.8
Data presented as percentage by weight. * e.g., calcium, magnesium, potassium, trace minerals.
2.2. Serum Vitamin D (25(OH)D) Concentration
Vitamin D status was measured using a 25-Hydroxy Vitamin D EIA kit (Immunodiagnostic
Systems, Tyne and Wear, UK) according to the manufacturer’s instructions.
2.3. Body Composition Changes
The effects of diet on somatic growth and body composition were assessed by measuring body
weight, body length (snout-vent), and gonadal fat pad mass, as a marker of adiposity.
2.4. Histopathological Assessment of Liver Pathology
Non-alcoholic fatty liver disease was assessed (under blinded conditions) by quantifying the
percentage of fat histologically using a stereological approach according to isotropic-uniform-random
(IUR) sampling principles. The left and caudate liver lobes were fixed, embedded at random orientation,
and then sectioned and stained with hematoxylin and eosin. Sectioning commenced at a random
starting point between 0–1000 µm and 5 µm sections were taken every 1000 µm thereafter.
Liver sections were randomly selected and analyzed using Visiopharm Integrator System
newCAST software (version 4.5.6, Visiopharm, Hørsholm, Denmark). The number of tissue point
counts and fat point counts in each section were used to calculate the proportion of fat per liver using
the stereology based volume density calculation method [24]. This approach has been found to be the
most accurate and reliable way of quantifying liver fat [25].
2.5. Hepatic Cytokine Expression
The expression of hepatic inflammatory markers were assessed by enzyme-linked immunosorbent
assay (ELISA). Protein from 22–30 mg of the median lobe of liver was extracted using a T-Per® Tissue
Protein Extraction Kit (Thermo Fisher Scientific, Scoresby, Victoria, Australia) with the addition of
Halt™ Protease and Phosphatase Inhibitor Cocktail (Thermo Fisher Scientific, Scoresby, Victoria,
Australia). Levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were assessed by ELISA
(DuoSet®, R&D Systems, Minneapolis, MN, USA), according to manufacturer’s instructions. Cytokine
protein levels were normalized to total tissue protein concentration, assessed by Bradford assay
(Commassie protein assay reagent, Sigma-Aldrich, Castle Hill, Australia).
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2.6. Glucose Tolerance Test
The presence and severity of insulin resistance were assessed by glucose tolerance test (GTT).
After five weeks on the assigned diet, mice were fasted overnight for at least 16 h. Blood was obtained
via tail snip and blood glucose measured using an Accu-Chek Performa glucometer (Roche, Bella Vista,
NSW, Australia). Fasting blood glucose concentrations were recorded before mice were administered a
glucose challenge (1 g/kg body weight) via an intraperitoneal injection. Blood glucose concentration
was then assessed every 15 min for 90 min post-injection.
2.7. Serum Insulin Concentration
Fasting insulin concentration was measured using a mouse insulin ELISA kit (Mercodia, Uppsala,
Sweden), according to the manufacturer’s instructions.
2.8. Statistical Analyses
Differences between groups were tested using two-way ANOVA with Holm-Sidak post-hoc tests
(SigmaPlot 12.5; SyStat Software Inc., San Jose, CA, USA). Multiple linear regression was used to
assess the associations between continuous variables (Stata 14 statistical software package, Stata Corp,
College Station, TX, USA). Data were transformed to satisfy the assumptions of normality and equal
variance where appropriate. p < 0.05 was considered statistically significant. Data are presented as
mean ± standard deviation, unless explicitly stated otherwise.
3. Results
3.1. Serum 25-Hydroxy Vitamin D Concentration
Both male and female mice fed vitamin D deficient diets had significantly lower 25(OH)D
concentrations than their respective vitamin D replete controls (male LF− vs. LF+: p < 0.001; male
HF− vs. HF+: p < 0.001; female LF− vs. LF+: p < 0.001; female HF− vs. HF+: p < 0.001). However, the
mice on the high fat vitamin D deficient diet had higher levels of 25(OH)D than the deficient mice on
the low fat diet (male HF− vs. LF-: p < 0.001; female HF− vs. LF−: p < 0.001), indicating that the high
fat diet feed increased 25(OH)D concentrations (Figure 2).
As a result, the mice on the HF− diet were not vitamin D deficient (25(OH)D < 50 nmol/L).
Consequently, data were analyzed, with sex as a factor in each, in a hierarchical fashion as follows:
i. The effect of a high fat diet was assessed by comparing outcomes in the replete mice on high fat
and low fat diets (LF+ vs. HF+)
ii. The effect of vitamin D deficiency was assessed by comparing outcomes in the low fat groups
(LF+ vs. LF−)
iii. The modifying effect of vitamin D concentration on the high fat response was assessed by
examining the relationship between vitamin D levels (as a continuous variable) and outcomes in
mice on the high fat diets (both HF+ and HF−).
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Figure 2. Serum 25-hydroxy vitamin D concentrations of adult C57BL/6 mice fed a low fat vitamin D
replete (LF+), low fat vitamin D deficient (LF−), high fat vitamin D replete (HF+), and high fat vitamin
D deficient (HF−) diet. Data shown as mean ± SD with n = 7–8 for each group, * p < 0.05.
3.2. Body Weight and Length
A high fat diet led to increased body weight in both sexes compared to a low fat control diet
(p < 0.001, Figure 3A).
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Figure 3. Body weight of adult C57BL/6 mice fed a low fat vitamin D replete (LF+), low fat vitamin D
deficient (LF−), and high fat vitamin D replete (HF+) diet. (Panel A) shows the effect of dietary fat
within vitamin D replete mice; (Panel B) shows the effect of vitamin D deficiency within low fat diet
fed mice. Data shown as mean ± SD, male groups n = 9, female groups n = 7–8, * p < 0.05.
Vitamin D deficiency decreased body weight in both male and female ice (p = . , i r ),
although the magnitude of this effect was small, ~0.6 g (3. % total body weight). 25(OH)D
concentratio di not significa tl if t effect a high fat diet had on body eight (p = 0.6 ,
Table 2). Males were longer than females (p < 0.001), and a high fat diet led to longer bodies in both
Nutrients 2017, 9, 985 6 of 14
sexes (p = 0.02), although the magnitude of the diet effect was small, ~1.5 mm (1.9% total length)
(Supplementary Figure S1).
Table 2. Multiple linear regression analysis for variables relating to metabolic function of adult C57BL/6
mice fed either a high fat vitamin D replete (HF+) or high fat vitamin D deficient (HF−) diet.
Outcome
25-Hydroxy Vitamin D Sex
β (95% CI) p β (95% CI) p
Body weight 0.007 (−0.021 0.035) 0.62 5.7 (4.5 7.0) <0.001
Body length 0.000 (−0.050 0.051) 0.99 5.1 (2.8 7.4) <0.001
Gonadal fad pad 2.507 (0.012 5.002) 0.049 234.3 (120.9 347.6) <0.001
Liver fat % −0.162 (−0.272 −0.051) 0.006 −15.9 (−20.9 −10.9) <0.001
GTT peak 0.021 (−0.029 0.071) 0.40 1.9 (−0.4 4.2) 0.10
AUC −1.051 (−3.560 1.458) 0.40 134.7 (20.7 248.6) 0.02
Fasting glucose 0.030 (−0.007 0.068) 0.11 1.3 (−0.4 3.0) 0.12
Fasting insulin 0.013 (0.006 0.019) 0.007 0.6 (0.2 1.0) 0.004
HOMA-IR 0.009 (0.001 0.018) 0.04 0.4 (0.0 0.8) 0.04
IL-6 protein 0.199 (−0.520 0.919) 0.06 −32.7 (−65.6 0.2) 0.05
TNF-α protein 4.117 (−2.368 10.602) 0.20 −152.5 (−449.1 144.1) 0.30
Regression co-efficient (β), 95% confidence intervals (95% CI), and p values displayed for the continuous variable
‘25-hydroxy vitamin D’ and categorical variable ‘Sex’ (positive co-efficient favors males, negative favors females).
GTT = glucose tolerance test, AUC = area under the curve, HOMA-IR = homeostatic model assessment for insulin
resistance, IL-6 = interleukin-6, TNF-α = tumor necrosis factor-α. Male groups n = 9, female groups n = 7–8, bold
numbers signifies p < 0.05.
3.3. Gonadal Fat Pad Weight
A high fat diet increased fat pad weight in both sexes (p < 0.001, Figure 4A). There was no effect of
vitamin D deficiency on gonadal fat pad weight in either sex (p = 0.39, Figure 4B), however 25(OH)D
concentration was significantly related to fat pad weight in mice fed a high fat diet (p = 0.049, Table 2)
such that higher 25(OH)D levels were associated with greater fat pad weight.
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3.4. Hepatic Fat Content 
A high fat diet increased hepatic fat content in both sexes (p < 0.001, Figure 5A,C,D). 
Interestingly, vitamin D deficiency alone increased liver fat accumulation in both male and female 
mice (p = 0.003, Figure 5B–D), while decreasing 25(OH)D concentrations were also associated with 
increased liver fat percentage in mice on a high fat diet (p = 0.006, Table 2). 
Figure 4. Gonadal fat pad weight of adult C57BL/6 mice fed a low fat vitamin D replete (LF+), low fat
vitamin D deficient (LF−), and high fat vitamin D replete (HF+) diet. (Panel A) shows the effect of
dietary fat within vitamin D replete mice; (Panel B) shows the effect of vitamin D deficiency within
low fat diet fed mice. Data shown as mean ± SD, male groups n = 9, female groups n = 7–8, * p < 0.05.
3.4. Hepatic Fat Content
A high fat diet increased hepatic fat content in both sexes (p < 0.001, Figure 5A,C,D). Interestingly,
vitamin D deficiency alone increased liver fat accumulation in both male and female mice (p = 0.003,
Figure 5B–D), while decreasing 25(OH)D concentrations were also associated with increased liver fat
percentage in mice on a high fat diet (p = 0.006, Table 2).
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= 0.06), a high fat diet caused increased IL-6 expression compared to a low fat diet (female LF+ vs. 
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Figure 5. Hepatic fat content in adult C57BL/6 mice fed a low fat vitamin D replete (LF+), low fat
vitamin D deficient (LF−), high fat vitamin D replete (HF+), and high fat vitamin D deficient (HF−)
diet. (Panel A) shows the effect of dietary fat within vitamin D replete mice; (Panel B) shows the effect
of vitamin D deficiency within low fat diet fed mice. Data shown as mean ± SD, male groups n = 9,
female groups n = 7–8, * p < 0.05; (Panel C) shows representative histological microscope images of
liver fat content in male mice; (Panel D) shows the equivalent images in female mice. Both high fat
and vitamin D deficient diets caused increased lipid accumulation in both sexes, although females had
greater lipid accumulation across each comparison.
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significantly related to IL-6 (p = 0.06) or TNF-α (p = 0.20) expression in mice on a high fat diet (Table 2).
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3.6. Insulin Sensitivity
A high fat diet had some impact on glucose tolerance in female, but not male mice (Figure 7A).
While there were no differences in fasting blood glucose, fasting insulin, or ho eostatic model
assessment for insulin resistance (HOMA-IR) (p > 0.057 for all comparisons, Table 3), within fe ales,
a high fat diet increased area under the curve (AUC) (female LF+ vs. HF+: p = 0.006, Figure 7C) and
GTT peak concentration (female LF+ 11.93± 1.34 mmol/L, female HF+ 16.30± 1.79 mmol/L: p = 0.001,
Supplementary Figure S2A). Compared to female ice, males had higher AUC (male vs. female within
LF: p < 0.001, Figure 7D; within HF: p = 0.02, Table 2), GTT peak (male 15.08 ± 1.52 mmol/L vs. fe ale
12.05 ± 1.60 mmol/L within LF: p < 0.001, Supplementary Figure S2B), HOMA-IR (male vs. female
within LF: p = 0.046, Table 4 ithin HF: p = 0.04, Table 2), and within a high fat diet at least, fasting
insulin (p = 0.004, Table 2) indicating greater insulin resistance.
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D deficiency respectively on total area under the curve (AUC) calculated from the GTT time course.
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Table 3. Insulin resistance measures for adult C57BL/6 mice fed either a low fat vitamin D replete
(LF+) or high fat vitamin D replete (HF+) diet.
Sex Diet
Fasting Blood Glucose Fasting Insulin HOMA-IR(mmol/L) (mU/L)
Males
LF+ 10.6 ± 1.9 4.06 ± 0.74 1.9 ± 0.5
HF+ 10.6 ± 1.8 4.06 ± 0.54 1.9 ± 0.5
Females
LF+ 8.9 ± 1.8 3.96 ± 0.79 1.5 ± 0.2
HF+ 9.7 ± 1.6 3.90 ± 0.57 1.7 ± 0.4
HOMA-IR = homeostatic model assessment for insulin resistance. Data shown as mean ± SD, male groups n = 9,
female groups n = 7–8.
Table 4. Insulin resistance measures for adult C57BL/6 mice fed either a low fat vitamin D replete
(LF+) or low fat vitamin D deficient (LF−) diet.
Sex Diet
Fasting Blood Glucose Fasting Insulin HOMA-IR
(mmol/L) (mU/L)
Males
LF+ 10.6 ± 1.9 4.06 ± 0.74 1.9 ± 0.5 *
LF− 9.8 ± 2.7 3.73 ± 0.41 1.6 ± 0.6 *
Females
LF+ 8.9 ± 1.8 3.96 ± 0.79 1.5 ± 0.2
LF− 8.4 ± 1.0 3.56 ± 0.29 1.4 ± 0.2
HOMA-IR = homeostatic model assessment for insulin resistance. Data shown as mean ± SD, male groups n = 9,
female groups n = 7–8. * Significant difference between sexes (p = 0.046).
Nutrients 2017, 9, 985 10 of 14
Vitamin D deficiency did not alter any insulin resistance measure (p > 0.087 for all comparisons,
Figure 7B,D, Tables 2 and 4) for either sex. However, increased 25(OH)D concentrations were associated
with increased fasting insulin (p = 0.007) and HOMA-IR (p = 0.04) for mice on a high fat diet (Table 2).
4. Discussion
The current study showed that a high fat diet causes increased fat deposition in both the
visceral fat pads and liver. Interestingly, vitamin D deficiency alone caused a similar increase in
fat accumulation within the liver, while also causing a mild decrease in insulin sensitivity. This is the
first study to demonstrate that vitamin D deficiency alone can cause increased hepatic fat accumulation,
substantiating the relationship between vitamin D deficiency and increased NAFLD seen in human
studies [18,19]. Importantly, this study also showed evidence for metabolic differences between male
and female mice. Male mice had increased visceral adiposity and decreased insulin sensitivity. This is
consistent with evidence from human studies, showing that males are more susceptible to visceral
fat accumulation [26] and insulin resistance [8]. In contrast, female mice had greater fat deposits in
the liver across all diets, and diminished insulin sensitivity on the high fat diet. The current study
provides novel evidence that females may be more susceptible to hepatic fat accumulation than males.
Importantly, the five and a half week high fat dietary intervention used in this study was of
sufficient duration to observe a redistribution in body weight and visceral adiposity. Similarly, striking
differences in hepatic fat content, the key marker of NAFLD, were observed between diets whereby
mice fed a high fat diet had increased liver fat percentage compared to mice fed a low fat diet.
This finding is consistent with previous studies in rats [21], and C57BL/6 mice [22], which have used a
more prolonged dietary intervention (>10 weeks) to induce an insulin resistant state. Therefore, the
results from the current studies shorter five and a half week dietary intervention assess an earlier
time-point in the development of metabolic dysfunction and show that hepatic fat accumulation and
alterations in fat storage occur during the early stages of disease progression.
Additionally, mice on a low fat vitamin D deficient diet had greater liver fat percentage than low
fat vitamin D replete mice, and in mice on a high fat diet, greater liver fat percentage was associated
with decreasing serum 25(OH)D concentrations. Both findings suggest that vitamin D is a key nutrient
in hepatic lipid homeostasis, with decreased vitamin D leading to increased fat accumulation in the
liver. Previous studies have shown vitamin D deficiency in combination with a high fat diet increases
liver fat in both rats [21] and mice [22], however this study is the first to demonstrate that vitamin
D deficiency alone can cause increased hepatic fat content and is also the first to demonstrate that
sex can influence the extent of this accumulation. The current results suggest that the association
between vitamin D deficiency and increased NAFLD in humans [18] could be causal, with 25(OH)D
deficient individuals potentially at risk of developing NAFLD. While several randomized controlled
trails [27,28] have shown vitamin D supplementation has not reversed NAFLD state in humans, these
trials have focused on subjects with established disease. As such, these studies are unable to assess if
there is any causal link between vitamin D deficiency and the risk of developing disease or its impact
on disease progression. Furthermore, these trials primarily assess liver enzymes as markers of NAFLD
and therefore have not directly assessed hepatic fat content. Our data suggest it may be important
for further trials to investigate if vitamin D supplementation can prevent or limit liver fat deposition
during early disease progression.
Intriguingly, female mice had higher liver fat percentages than male mice, across all group
comparisons. This is inconsistent with the results of a previous study [29] examining potential sex
differences in liver fat accumulation of C57BL/6 mice fed a high fat diet. One potential explanation for
the inconsistent results is the method used to quantify fat in the liver as many animal studies have
used semi-quantitative methods [21,29] to determine hepatic fat percentage. A strength of the current
study is the use of stereological point counting, which is more sensitive at quantifying differences, and
is the preferred method for liver fat assessment [25].
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It is recognized that inflammatory cytokines play a key role in the progression of NAFLD, from
passive fat accumulation to steatohepatitis [30]. Increased cytokine expression, particularly IL-6
and TNF-α, is a proposed mechanism for vitamin D deficient induced progression of NAFLD that
has been demonstrated in both humans [31] and animal models [21]. There was however, nothing
to suggest that IL-6 or TNF-α had increased in concert with hepatic fat accumulation in our study.
This may be due to the short intervention protocol which has allowed early events in the metabolic
disturbance to be assessed. Inflammation is likely to occur over a more prolonged period and possibly
as a result of the increased hepatic fat accumulation rather than being a causative factor. Our data
suggests that vitamin D deficiency increases hepatic fat accumulation independent of common hepatic
inflammation mediators.
Male mice appeared to be less insulin sensitive than female mice. Specifically, compared to female
mice, males had increased AUC, GTT peak, fasting insulin, and HOMA-IR scores. However, female
mice were affected by a high fat diet with increased blood glucose concentrations in the first 30 min
following the glucose challenge. This led to increased AUC and GTT peak compared to low fat diet
fed females. Interestingly, male mice were not adversely affected by a high fat diet. This suggests that
although male mice were less insulin sensitive than females at baseline, females are more susceptible
to the subsequent effects of exposure to a high fat diet. This may explain the sex discrepancy in the
human data whereby males are at higher risk of disease [8] (higher baseline insulin resistance) while
females often have more severe disease (more sensitive to metabolic insults) [11].
While there were significant associations between increasing 25(OH)D and both fasting insulin
concentrations and HOMA-IR scores in mice on a high fat diet, the size of the effect was modest.
Furthermore, there were no associations between 25(OH)D and fasting blood glucose, AUC, or GTT
peak. Equally, mice on a low fat vitamin D deficient diet had no alterations in insulin sensitivity
compared to vitamin D replete mice. As the lard component of the high fat diet was the most likely
source of erroneous vitamin D in the HF− group, there is a possibility that the within high fat diet
vitamin D associations found in the current study may be at least partly related to the amount of high
fat diet consumed. Animals that ate more, would have not only consumed higher fat content, but also
higher amounts of vitamin D, thus resulting in the associations between higher 25(OH)D and plasma
insulin and HOMA-IR. This suggests that 25(OH)D concentration has a minimal effect on insulin
sensitivity. Still, it must be stated that the association between 25(OH)D and increased fasting plasma
insulin coupled with the association between 25(OH)D and decreased liver fat accumulation seen
within the high fat diet fed animals is highly unusual for this model. Of course it is possible that the
model used was of insufficient duration to observe the true or longer term effects, which is plausible
given that insulin sensitivity was only marginally diminished in many animals. In future studies it
may be appropriate to use a longer dietary intervention to allow greater insulin resistance to develop,
in order to tease out the full effect on insulin sensitivity caused by 25(OH)D deficiency.
There are a number of limitations that should be acknowledged in the current study. The high fat
vitamin D deficient diet seemingly contained unintended vitamin D, leaving mice on this diet with
significantly higher serum 25(OH)D concentrations than low fat vitamin D deficient fed mice. This
most likely occurred as a result of the animal fat (lard) component of the commercially manufactured
high fat diet, containing inadvertent fat-soluble vitamin D. As such our study did not include a true
high fat vitamin D deficient group, leading to our stratified analytical approach. Additionally, previous
studies [21,22] have used extended intervention periods, that potentially allowed more pronounced
insulin resistance to develop and consequently highlighted biological differences more starkly. While
the current study aimed to uncover early disease progression, it accordingly resulted in only modest
disturbances to insulin sensitivity. Interestingly, while only slight decreases to insulin sensitivity were
observed, large differences were detected in hepatic fat content between groups. This could have
implications for early detection of metabolic dysfunction. It should be noted that food intake and
physical activity were not measured in the current study. Given the lack of difference in gonadal
fat pad weight and minimal body weight differences seen within low fat diet fed animals, major
Nutrients 2017, 9, 985 12 of 14
differences to physical activity and food intake appear unlikely. Nevertheless, these factors could
partially explain some of the other metabolic differences observed within low fat diet groups.
While acknowledging these limitations, the current study has enhanced our understanding of
the potential impact of vitamin D deficiency on the development of early metabolic dysfunction.
The majority of the metabolic disturbances were due to a high fat diet, however vitamin D deficiency
had a significant effect on hepatic fat accumulation regardless of diet composition. This suggests the
relationship between vitamin D deficiency and NAFLD observed in human populations [18,19] could
be causal. Major sex differences were uncovered in the current study. Consistent with the human data,
the current study found female mice were generally more insulin sensitive [8], weighed less, and had
less visceral fat mass [26] than male mice. Contrary to previous findings in humans [6,7], female mice
also had greater hepatic fat deposition than male mice, although this may be due to methodological
differences. Importantly, this study shows that hepatic fat accumulation may be one of the earliest
signs of metabolic dysfunction, with insulin resistance taking longer to fully develop.
5. Conclusions
Overall, this study suggests that 25(OH)D deficiency and a high fat diet have independent
adverse effects on metabolic health and show that vitamin D deficiency alone, may contribute to
an increase in hepatic fat content. This data shows that hepatic fat accumulation may be an early
event in the progression of metabolic dysfunction. Our data also suggests that males are at greater
risk of developing increased visceral adiposity and insulin resistance while females are at greater
risk of hepatic fat accumulation, demonstrating the need to study both sexes to fully understand the
mechanisms that contribute to disease development and its progression.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6643/9/9/985/s1,
Figure S1: Body length, Figure S2: Peak blood glucose concentrations.
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